These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Nestin is significantly associated with the overall survival of nonsmall cell lung cancer: A meta-analysis.
    Author: Zhang D, Wang J.
    Journal: J Cancer Res Ther; 2020; 16(4):800-803. PubMed ID: 32930121.
    Abstract:
    AIMS: Some studies investigated the association between nestin and the overall survival (OS) of nonsmall cell lung cancer (NSCLC). However, the results were conflicted and inconclusive. Therefore, we performed this meta-analysis to determine the association between nestin and OS of NSCLC. MATERIALS AND METHODS: PubMed and EMBASE were searched to find relevant studies. The strength of the association was calculated with the hazard ratios (HRs) and respective 95% confidence intervals (CIs). RESULTS: High expression of nestin was significantly associated with OS of NSCLC (HR = 2.09; 95% CI = 1.59-2.77). In the stratified analysis by race, we found that the expression of nestin was significantly associated with OS of NSCLC in Asians (HR = 3.02; 95% CI = 1.80-5.07) and Caucasians (HR = 1.81; 95% CI = 1.21-2.71). In addition, when we limited the meta-analysis to studies that controlled for clinical parameters, a significant association between nestin and OS of NSCLC remained (HR = 2.19; 95% CI = 1.54-3.11). A sensitivity analysis showed no substantial modification of the estimates after exclusion of individual studies. CONCLUSIONS: In conclusion, this meta-analysis suggested that high expression of nestin was significantly associated with OS of NSCLC.
    [Abstract] [Full Text] [Related] [New Search]